News | Molecular Imaging | June 13, 2017

SNMMI Elects Bennett S. Greenspan, M.D., MS, FACNM, FACR, as President

During 2017 annual meeting new officers elected for 2017-2018

Bennett S. Greenspan, M.D.

Bennett S. Greenspan, M.D.

Bennett S. Greenspan, M.D., MS, FACNM, FACR, professor of radiology at the Medical College of Georgia, Augusta University, in Augusta, Ga., has assumed office as 2017-18 president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2017 Annual Meeting, June 10-14, in Denver, Colorado.      

“As SNMMI President, in the year ahead I will focus on the new Value Initiative and strategic plan, which emphasize quality of practice; research and development; strengthening education and the workforce pipeline; advocacy for molecular imaging, nuclear medicine, and targeted therapy procedures that improve patient care; and outreach that explains the field’s critical role in modern medicine,” Greenspan said.

With the focus on quality and value, Greenspan will continue SNMMI’s development of appropriate use criteria (AUC) and updating procedure guidelines for many nuclear medicine imaging procedures. He will also work on establishing more efficient and timely approval of novel radiotracers. His ultimate focus is on improving patients’ lives. “These improvements can lead to more appropriate utilization of diagnostic nuclear medicine exams and also radionuclide therapy, which will benefit patients,” he explained. “These goals can be facilitated by working closely with other societies and governmental agencies.”

Prior to his position as professor of radiology at the Medical College of Georgia at Augusta University, Greenspan worked at the Mount Sinai School of Medicine in New York, N.Y.; University of Rochester in Rochester, N.Y.; University of Missouri-Columbia; and Washington University in St. Louis, MO.  Greenspan is devoted to teaching clinical nuclear medicine, as well as nuclear medicine physics and radiation safety, to nuclear medicine and radiology residents. He is a member of three committees of the American Association of Physicists in Medicine (AAPM): one on teaching medical physics to radiology residents, one on the development of the medical physics curriculum for radiology residents, and one on the physics of nuclear medicine.

Consistent with his keen interest in ensuring that nuclear medicine delivers the highest quality of care, Greenspan serves on the SNMMI Quality and Evidence Committee, is a reviewer for quality assurance in nuclear medicine for the American College of Radiology (ACR), and was a member of the PET Quality and Reporting Task Force of SNMMI’s PET Center of Excellence. He is a co-author of the paper “Reporting Guidance for Oncologic FDG PET/CT Imaging,” published in the May 2013 issue of The Journal of Nuclear Medicine.

Greenspan holds a Master of Science degree in medical physics from the University of California, Los Angeles, and earned his medical degree at the University of Illinois in Chicago. He served residencies in diagnostic radiology and nuclear medicine and is certified in diagnostic radiology and nuclear radiology by the American Board of Radiology (ABR) and in nuclear medicine by the American Board of Nuclear Medicine (ABNM).

Greenspan’s research and scholarly interests include PET/CT imaging in oncology, especially using PET imaging to further characterize malignancies; evaluation of osteoporosis; and the effects of low-level radiation. He has been a co-investigator on 11 grants.

Greenspan is a Fellow of the ACR and the American College of Nuclear Medicine (ACNM). He currently serves on the boards of the American Board of Science in Nuclear Medicine and the Nuclear Medicine Technology Certification Board. He is past chair of the SNMMI Committee on Councils and served as co-chair of the ACR Nuclear Medicine Procedure Guidelines Committee.

He has been president of the American College of Nuclear Physicians (ACNP), the Missouri Radiological Society, the SNMMI Academic Council (twice), the Missouri Valley Chapter of SNMMI (twice) and the American Board of Science in Nuclear Medicine. At SNMMI, he has served on the Board of Directors and on the boards of the Academic Council, Advanced Associate Council, Nuclear Oncology Council and Computer and Instrumentation Council. Greenspan has also served on the boards of the ACNM, the Intersocietal Commission for the Accreditation of Computed Tomography Laboratories (now the Intersocietal Accreditation Commission – IAC), and the Academy of Radiology Research, as well as on the executive councils of the ACNP and the ACR Intersociety Summer Conference. Greenspan continues to serve on numerous committees and task forces of the SNMMI, ACNM, ACR, Radiological Society of North America, Association of University Radiologists, AAPM and NMTCB. He has also been an ABR oral board examiner. 

Other SNMMI officers elected for 2017-18 are Satoshi Minoshima, M.D., Ph.D., Salt Lake City, Utah, as president-elect, and Vasken Dilsizian, M.D., Baltimore, Maryland, as vice president-elect. SNMMI Technologist Section officers for 2017-18 are Kathleen Krisak, CNMT, FSNMMI-TS, Granby, Mass., as president, and Norman Bolus, MSPH, CNMT, FSNMMI-TS, Birmingham, Alabama, as president-elect.

 

For more information: www.snmmi.org

Related Content

Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
Brain-scan guided emergency stroke treatment can save more lives
News | Neuro Imaging | January 25, 2018
January 25, 2018 – Advances in brain imagin...
PET Tracer Measures Damage From Multiple Sclerosis in Mouse Models
News | PET Imaging | January 24, 2018
January 24, 2018 — The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallma
Novel PET Tracer Clearly Identifies and Tracks Bacterial Lung Infection

Representative PET/CT images of 18F-FDS and 18F-FDG in inflamed mice. Mice were inoculated with dead K. pneumoniae (10^8 CFU/mL). Imaging was performed for days 1, 2, 3 and 4 using 18F-FDG and 18F-FDS. CT images showed clear inflammation on day 2 and day 3 with corresponding high 18F-FDG uptake on PET. No significant uptake of 18F-FDS was detected for any of those 4 days. Credit: J Li et al., University of Louisville School of Medicine, Louisville, Ky.

News | PET-CT | January 22, 2018
January 22, 2018 — Researchers at the University of Louisville, Kentucky, have demonstrated that a new...
PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Overlay Init